MTIM
IMGN

Marathon Trading Investment Management’s Immunogen Inc IMGN Stock Holding History

Marathon Trading Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,000
Closed -$109K – 227
2019
Q3 		$109K Buy
45,000
+22,800
+103% +$60.5K 0.02% 175
2019
Q2 		$48K Buy
+22,200
New +$52.5K ﹤0.01% 214

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marathon Trading Investment Management's IMGN Position: Q4 2019 in Review

Marathon Trading Investment Management sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 45,000 shares — an estimated $109K sold.

Marathon Trading Investment Management first reported a position in IMGN in Q2 2019 and held it in 2 quarters. The position peaked at $109K in Q3 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • Marathon Trading Investment Management reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
  • Marathon Trading Investment Management sold 45,000 Immunogen Inc shares in Q4 2019, an estimated $109K.
  • Marathon Trading Investment Management first reported a position in Immunogen Inc in Q2 2019 and held it in 2 quarters.
  • Marathon Trading Investment Management's Immunogen Inc position peaked at $109K in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Marathon Trading Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.